# Medtronic (MDT) — Earnings

MDT · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/mdt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q1 2027 |
| Period end | Jul 31, 2026 |
| EPS actual | $1.45 |
| EPS estimate | $1.39 |
| EPS surprise | +4.44% |
| Revenue surprise | +2.20% |
| Revenue | $9.8B |
| Revenue estimate | $9.5B |
| Reported | Sep 1, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1613103/000162828026060473/mdt-20260731.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/be4b8a61-5905-d911-bdac-50caa1d89d7c.html) |

Medtronic reported fiscal Q1 2027 results on September 1, 2026. Earnings per share were $1.45, beating the $1.39 estimate by 4.44%. Revenue was $9.8 billion, 2.20% above the $9.5 billion consensus. Compared with fiscal Q1 2026, EPS rose about 15% from $1.26 and revenue rose about 14% from $8.6 billion.

The table covers 13 quarters, back to fiscal Q1 2024. Annual EPS rose from $5.21 in fiscal 2024 to $5.50 in 2025 and $5.53 in 2026. Annual revenue grew from $32.4 billion to $33.6 billion and then $36.4 billion. Fiscal Q4 was the strongest EPS quarter in each complete year, and Q4 2025 holds the high in the table at $1.62. Fiscal Q1 has been the weakest each year, yet Q1 2027 matched the top revenue figure here at $9.8 billion, level with Q4 2026. Medtronic beat EPS estimates in all 13 quarters, by margins between 0.63% and 8.16%.

Medtronic reported fiscal Q2 between November 18 and November 21 in each of the past three years. That points to mid-to-late November 2026 for the next report. It will show whether the year-over-year gains of fiscal Q1 carry into the second quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q1 2027 | Sep 1, 2026 | $1.39 | $1.45 | 4.44% | $9.5B | $9.8B |
| Q4 2026 | Jun 3, 2026 | $1.54 | $1.55 | 0.64% | $9.6B | $9.8B |
| Q3 2026 | Feb 17, 2026 | $1.34 | $1.36 | 1.82% | $8.9B | $9.0B |
| Q2 2026 | Nov 18, 2025 | $1.31 | $1.36 | 3.49% | $8.9B | $9.0B |
| Q1 2026 | Aug 19, 2025 | $1.23 | $1.26 | 2.53% | $8.4B | $8.6B |
| Q4 2025 | May 21, 2025 | $1.58 | $1.62 | 2.46% | $8.8B | $8.9B |
| Q3 2025 | Feb 18, 2025 | $1.36 | $1.39 | 2.23% | $8.3B | $8.3B |
| Q2 2025 | Nov 19, 2024 | $1.25 | $1.26 | 0.83% | $8.3B | $8.4B |
| Q1 2025 | Aug 20, 2024 | $1.20 | $1.23 | 2.59% | $7.9B | $8.0B |
| Q4 2024 | May 23, 2024 | $1.45 | $1.46 | 0.63% | $8.5B | $8.6B |
| Q3 2024 | Feb 20, 2024 | $1.26 | $1.30 | 3.04% | $8.0B | $8.1B |
| Q2 2024 | Nov 21, 2023 | $1.18 | $1.25 | 5.78% | $7.9B | $8.0B |
| Q1 2024 | Aug 22, 2023 | $1.11 | $1.20 | 8.16% | $7.6B | $7.7B |

## Frequently Asked Questions

### When did Medtronic (MDT) last report earnings?

Medtronic last reported on Sep 1, 2026, covering fiscal Q1 2027.

### Did MDT beat earnings estimates?

Yes. Medtronic reported EPS of $1.45 for Q1 2027 against a $1.39 estimate — a 4.44% beat.

### How much revenue did MDT report last quarter?

Medtronic reported $9.8B in revenue for Q1 2027, against a consensus estimate of $9.5B.

## Similar Stocks

- [SYK](https://www.lighthorse.io/tickers/syk) — Stryker Corporation Common Stock
- [ISRG](https://www.lighthorse.io/tickers/isrg) — Intuitive Surgical, Inc. - Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [ABT](https://www.lighthorse.io/tickers/abt) — Abbott Laboratories Common Stock
- [BSX](https://www.lighthorse.io/tickers/bsx) — Boston Scientific Corporation Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock
- [NVST](https://www.lighthorse.io/tickers/nvst) — Envista Holdings Corporation Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [PHG](https://www.lighthorse.io/tickers/phg) — Koninklijke Philips N.V. NY Registry Shares
- [GEHC](https://www.lighthorse.io/tickers/gehc) — GE HealthCare Technologies Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).